Thought Leadership
An Overview of Generative AI and Machine Translation for Life Sciences
Global life sciences companies are realizing the potential artificial intelligence (AI) and machine learning (ML) has to drive efficiency in content and translation management. To capitalize on this, organizations need to identify the right solutions. Discover important...
6 Pathways to Take Your MT Strategy to the Next Level in 2024
With 2024 well underway, innovators in the global life sciences and pharmaceutical industries continue to question how to maximize efficiencies and reduce complexities in clinical and regulatory content development and localization. As part of the broader technological roadmap,...
LifeSci Talks COA Series | Breaking the Hype Cycle: An Objective Look at Remote Research Strategies in DCTs
In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire, CEO of Medable, spoke about how a Stanford doctor transitioned into a career of entrepreneurship, creating a...
LifeSci Talks COA Series | Exploring the Intersection of Clinical Practice and Entrepreneurship: Technological Innovation in Clinical Research
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the...
Clinical Outcomes Assessments (COAs) in Clinical Trials: Copyright and Licensing
Navigating the intricate details of licensing and copyright agreements in COAs is a complex task, presenting possible challenges to multi-licensor coordination or in managing evolving study protocols. This complexity, however, is a necessity, serving as an essential tool to...
How to Approach the Protection of Personal Data and Commercially Confidential Information of EU Clinical Trial Applications: Practical Considerations
In this piece, we'll explore the two primary frameworks that are driving EU CTR transparency efforts: the European Medicines Agency’s Policy 70 and Regulation (EU) No. 536/2014 on clinical trials. Gain valuable insight into requirements, exceptions, and implications for all...
Localizing Platforms for Digital Health: The Importance of Post-Localization Context Review
In a landscape defined by continuous technological advancement, many organizations in the life sciences industry strive to increase audience engagement through digital modalities, such as mobile and web applications or web portals. Building a robust technological...
C3 Summit London 2024
THE BREWERY 52 Chiswell St London EC1Y 4SA United Kingdom...
Unlocking the Power of AI and Machine Learning in Life Sciences
Life sciences companies are putting artificial intelligence (AI) and machine learning (ML) into practice, realizing its potential to revolutionize adverse event detection, diagnostics, and more. For AI and ML to be truly effective, you need to give context to your data, teaching...
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From...
Navigating the Bias Challenge: Medical Data for Ethical AI in Life Sciences
From drug discovery to personalized medicine, AI systems are broadly transforming how we approach health and disease. The clinical development life cycle generates enormous volumes of data, and its potential is fully realized through the strategic application of AI tools, such as...
Achieving Global Success in Clinical Trial Recruitment
TransPerfect's GlobalLink Connect integration with Adobe Experience Cloud enabled one of the world’s largest pharmaceutical companies to help visitors in 17 countries and 13 languages identify clinical trials that might be right for them or their loved ones....
4 Immediate Applications for AI Translation in Pharma
Precision and speed are key facets of success in the dynamic world of pharmaceutical development. To achieve these goals, AI-powered capabilities, such as machine translation (MT), can have a considerable and transformative impact. Automated translation workstreams enable...
Clinical Content Trends: 2023 Reflections and 2024 Projections
Over the past decade, the pharmaceutical industry has transformed significantly, giving way to breakthrough therapeutics and innovations for improved patient outcomes around the world. With these changes, there’s also been significant developments in the way organizations are...
LifeSci Talks COA Series | Licensing Challenges vs. eCOA Vendor Capabilities
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among...
COA White Paper | The Tale of Two Trials
In “The Tale of Two Trials,” Mark Wade takes an in-depth look at the benefits and drawbacks of the traditional, paper-based outcomes assessment method, as well as the advantages of the emerging electronic clinical outcomes assessment (eCOA) solutions. With each having the...
Data Standardization COA Whitepaper
With the surge of eCOA providers deploying differing technology platforms with differing architecture and file exchange processes, the landscape is shifting and becoming opaque. Deploying an eCOA solution faster and more costeffectively is a clearer focus for Sponsors now. Indeed...
LifeSci Talks COA Series | Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host of new challenges, including those surrounding technical interoperability, resistance to adopting new technologies, and the need for...
ICH E6(R3): Understanding the Updated Good Clinical Practice Guidelines (GCP) and Their Future Impact
The International Council for Harmonization (ICH) announced revisions to its Good Clinical Practice (GCP) guidelines, marking a significant move towards more closely aligning clinical practice with the rapidly evolving technological and regulatory landscape. What are the key...
Buyer’s Guide: PV Reporting AI and Automation
Considerations for selecting modern pharmacovigilance (PV) and safety solutions that improve adverse event detection, assessment, understanding and prevention. Download your copy to gain expert insights into developing and implementing a robust automation strategy for PV &...
Keeping Patients at the Heart of Clinical Trials
Clinical trial patient recruitment continues to be challenging. Even with shifts to decentralize clinical trials and the addition of new vendors and technology, recruitment still is the primary cause of delays or discontinuation. What could we be missing? In this webinar, we...
The Imperative of Automation in Pharmacovigilance and Patient Safety
Uncover the transformative potential of tech-enabled pharmacovigilance (PV) processes to maximize patient safety and streamline reporting. This white paper outlines the practical application of Artificial Intelligence (AI), Translation Management Systems (TMS), and other...
LifeSci Talks COA Series | AI-Powered Innovations in Clinical Trials: Optimizing Every Step
Explore how artificial intelligence is rapidly changing the landscape of clinical trials, from discovering new therapies and complex calculations to protocol optimization. Discover how AI can generate study protocols, consent forms, and more, saving time and resources. Join us to...
The Role of Artificial Intelligence (AI) in Clinical Outcome Assessments (COAs)
Artificial Intelligence (AI) is the new frontier for content creation, reuse of language assets; saving time and effort in the curation of documentation. The widely adopted generative AI tools, such as ChatGPT have altered the landscape, in many instances transforming authors...